GALERA THERAPEUTICS, INC. (a Delaware corporation) [●] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 28th, 2019 • Galera Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 28th, 2019 Company Industry Jurisdiction
GALERA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 28th, 2019 • Galera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 28th, 2019 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ______________, 20[19] between Galera Therapeutics, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
GALERA THERAPEUTICS, INC. EMPLOYMENT, CONFIDENTIALITY, NONCOMPETE AND INVENTION RIGHTS AGREEMENTEmployment Agreement • October 28th, 2019 • Galera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 28th, 2019 Company Industry JurisdictionThis Employment, Confidentiality, Noncompete and Invention Rights Agreement (“Agreement”) is made and entered into as of October 25, 2019 by and between Galera Therapeutics, Inc., a Delaware corporation (the “Company”), and Jon T. Holmlund, M.D. (“Employee”).
GALERA THERAPEUTICS, INC. EMPLOYMENT, CONFIDENTIALITY, NONCOMPETE AND INVENTION RIGHTS AGREEMENTEmployment, Confidentiality, Noncompete and Invention Rights Agreement • October 28th, 2019 • Galera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 28th, 2019 Company Industry JurisdictionThis Employment, Confidentiality, Noncompete and Invention Rights Agreement (“Agreement”) is made and entered into as of October 25, 2019 by and between Galera Therapeutics, Inc., a Delaware corporation (the “Company”), and Robert A. Beardsley, Ph.D. (“Employee”).
GALERA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 28th, 2019 • Galera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 28th, 2019 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 30th day of August, 2018, by and among Galera Therapeutics, Inc., a Delaware corporation (the “Company”) and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”